<DOC>
	<DOC>NCT00605917</DOC>
	<brief_summary>The objective of this surveillance is to collect information for panic disorder patients about 1) adverse drug reactions not expected from the LPD (unknown adverse drug reactions), 2) the incidence of adverse drug reactions in this surveillance, and 3) factors considered to affect the safety and/or efficacy of this drug.</brief_summary>
	<brief_title>Special Investigation Of J Zoloft For Panic Disorder Patients</brief_title>
	<detailed_description>All patients with panic disorder to whom an investigator prescribes the first sertraline hydrochloride should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into the investigation at random.</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Panic Disorder</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Patients with panic disorder need to be taking sertraline hydrochloride in order to be enrolled in the surveillance. Patients not taking sertraline hydrochloride.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>